Our preferred hypothesis is that TGFβ plays a dominant role in the conversion of CD4+ T cells to iTreg cells, because TGFβ is known to be produced in cancer tissue, is associated with an immunosuppressive state and induces the expansion of Treg cells [44]. The gene discussed is CD4; the disease is cancer.